Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2023
About
Suggestions
Contact Us
KU-32 compound
MeSH Supplementary Concept Data 2024
Details
Concepts
MeSH Supplementary
KU-32 compound
Unique ID
C581040
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C581040
Entry Term(s)
N-(7-((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyl-tetrahydro-2H-pyran-2-yloxy)-8-methyl-2-oxo-2H-chromen-3-yl)acetamide
Registry Number
0
Heading Mapped to
Novobiocin
/
*analogs & derivatives
Frequency
6
Note
a novobiocin-based Hsp90 inhibitor, safe for human islets and improves in vitro insulin secretion and viability
Source
Exp Diabetes Res. 2012;2012() (dup#98):671673
Indexing Information
Diabetes Mellitus, Type 2
Neuroprotective Agents
Date of Entry
2013/05/13
Revision Date
2014/02/28
Expand All
Collapse All
KU-32 compound
Preferred
Concept UI
M0584735
Registry Number
0
Terms
KU-32 compound
Preferred Term
Term UI
T844083
Date
05/13/2013
LexicalTag
NON
ThesaurusID
NLM (2013)
N-(7-((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyl-tetrahydro-2H-pyran-2-yloxy)-8-methyl-2-oxo-2H-chromen-3-yl)acetamide
Broader
Concept UI
M0591926
Terms
N-(7-((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyl-tetrahydro-2H-pyran-2-yloxy)-8-methyl-2-oxo-2H-chromen-3-yl)acetamide
Preferred Term
Term UI
T855764
Date
02/28/2014
LexicalTag
NON
ThesaurusID
NLM (2014)
page delivered in 0.005s